The role of Topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer

被引：0
|
作者：
Gamea, M. [1 ]
机构：
[1] Aswan Univ, Clin Oncol, Tanta, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
389 (PB-02
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy in locally advanced breast cancer
    Singh, G
    Singh, DP
    Gupta, D
    Muralikrishna, BV
    JOURNAL OF SURGICAL ONCOLOGY, 1996, 61 (01) : 38 - 41
  • [22] Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Iqbal, Javeria
    Shafi, Alam Ara
    Alharthi, Bandar N.
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (11): : 845 - 848
  • [23] Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
    Specht, Jennifer
    Gralow, Julie R.
    SEMINARS IN RADIATION ONCOLOGY, 2009, 19 (04) : 222 - 228
  • [24] Neoadjuvant chemotherapy for locally advanced breast cancer
    Fomenko, Y.
    Sirota, V.
    Bitz, U.
    Zhumakaeva, S.
    Omarova, I.
    Kabildina, N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] Role of breast imaging with histopathological correlation in evaluating the response of locally advanced breast cancer to neoadjuvant chemotherapy
    Syed, Anjum
    Premi, Vimugdha
    Varghese, Reshma
    Arora, Manali
    Kapoor, Aakriti
    Kattupalli, Satish
    Sharda, Prateek
    Gupta, Manoj
    Ravi, Bina
    BREAST JOURNAL, 2020, 26 (11): : 2272 - 2275
  • [26] Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2α Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
    Eralp, Yesim
    Keskin, Serkan
    Akisik, Ebru
    Akisik, Elif
    Igci, Abdullah
    Muslumanoglu, Mahmut
    Yilmaz, Sabri
    Tunaci, Mehtap
    Camlica, Hakan
    Tuzlali, Sitki
    Saip, Pinar
    Dalay, Nejat
    Ozmen, Vahit
    Topuz, Erkan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (03): : 215 - 223
  • [27] Predictive value of the immunohistochemical detection of topoisomerase IIα (Topo IIα) in breast cancer treated by primary chemotherapy.
    MacGrogan, G
    Rudolph, P
    Mauriac, L
    Durand, M
    Avril, A
    Dilhuydy, JM
    Flocquet, A
    de Mascarel, I
    Mathoulin-Pelissier, S
    Parwaresch, R
    Coindre, JM
    MODERN PATHOLOGY, 2001, 14 (01) : 31A - 31A
  • [28] Predictive value of the immunohistochemical detection of Topoisomerase IIα (Topo IIα) in breast cancer treated by primary chemotherapy.
    MacGrogan, G
    Rudolph, P
    Mauriac, L
    Durand, M
    Avril, A
    Dilhuydy, JM
    Flocquet, A
    de Mascarel, I
    Mathoulin-Pélissier, S
    Parwaresch, R
    Coindre, JM
    LABORATORY INVESTIGATION, 2001, 81 (01) : 31A - 31A
  • [29] Role of tumor cellularity in the assessment of response to neoadjuvant chemotherapy treated locally advanced breast cancer
    Kumar, S.
    Badhe, B. A.
    Krishnan, K. M.
    Kadambari, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S447 - S447
  • [30] Search for predictive biomarkers of response to neoadjuvant chemotherapy in locally advanced gastric cancer
    Oshima, Takashi
    Yoshikawa, Takaki
    Morita, Satoshi
    Miyagi, Yoichi
    Tanabe, Kazuaki
    Nishikawa, Kazuhiro
    Ito, Yuichi
    Aoyama, Toru
    Rino, Yasushi
    Masuda, Munetaka
    Sakamoto, Junichi
    CANCER SCIENCE, 2018, 109 : 767 - 767
12345